Pharma & Healthcare
Global Conjugate Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 28, 25
- ID: 341020
- Pages: 127
- Figures: 134
- Views: 1
In 2024, the global market size of Conjugate Vaccine was estimated to be worth US$ 10640 million and is forecast to reach approximately US$ 13220 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
Market competition is intense. Pfizer, GSK, Sanofi, Merck, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 86.11% market share in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Conjugate Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conjugate Vaccine.
The Conjugate Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Million Unit) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Conjugate Vaccine market comprehensively. Regional market sizes, concerning products by Type, by End Users, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Conjugate Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End Users, and regions.
By Company
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Segment by Type
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Segment by End Users
Children
Adult
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by End Users, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Conjugate Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Conjugate Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Conjugate Vaccine sales, revenue, price, gross margin, sales by region, by Type, by End Users, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by End Users, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by End Users and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by End Users and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by End Users and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by End Users and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by End Users and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
Market competition is intense. Pfizer, GSK, Sanofi, Merck, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 86.11% market share in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Conjugate Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conjugate Vaccine.
The Conjugate Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Million Unit) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Conjugate Vaccine market comprehensively. Regional market sizes, concerning products by Type, by End Users, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Conjugate Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End Users, and regions.
By Company
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Segment by Type
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Segment by End Users
Children
Adult
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by End Users, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Conjugate Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Conjugate Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Conjugate Vaccine sales, revenue, price, gross margin, sales by region, by Type, by End Users, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by End Users, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by End Users and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by End Users and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by End Users and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by End Users and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by End Users and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Conjugate Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Conjugate Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Hib Vaccine
1.2.3 Meningococcal Vaccine
1.2.4 Pneumococcal Vaccine
1.2.5 Others
1.3 Market by End Users
1.3.1 Global Conjugate Vaccine Market Size Growth Rate by End Users (2020 VS 2024 VS 2031)
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Conjugate Vaccine Market Size Estimates and Forecasts
2.1.1 Global Conjugate Vaccine Revenue 2020-2031
2.1.2 Global Conjugate Vaccine Sales 2020-2031
2.2 Conjugate Vaccine Market Size by Region: 2024 Versus 2031
2.3 Conjugate Vaccine Sales by Region (2020-2031)
2.3.1 Global Conjugate Vaccine Sales by Region: 2020-2025
2.3.2 Global Conjugate Vaccine Sales Forecast by Region (2026-2031)
2.3.3 Global Conjugate Vaccine Sales Market Share by Region (2020-2031)
2.4 Conjugate Vaccine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Conjugate Vaccine Revenue by Region: 2020-2025
2.4.2 Global Conjugate Vaccine Revenue Forecast by Region (2026-2031)
2.4.3 Global Conjugate Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Conjugate Vaccine Sales by Type (2020-2031)
3.1.1.1 Global Conjugate Vaccine Sales Volume by Type (2020-2031)
3.1.1.2 Global Conjugate Vaccine Sales Market Share by Type (2020-2031)
3.1.2 Global Conjugate Vaccine Revenue by Type (2020-2031)
3.1.2.1 Global Conjugate Vaccine Revenue by Type (2020-2031)
3.1.2.2 Global Conjugate Vaccine Revenue Market Share by Type (2020-2031)
3.1.3 Conjugate Vaccine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by End Users
3.2.1 Global Conjugate Vaccine Sales by End Users (2020-2031)
3.2.1.1 Global Conjugate Vaccine Sales Volume by End Users (2020-2031)
3.2.1.2 Global Conjugate Vaccine Sales Market Share by End Users (2020-2031)
3.2.2 Global Conjugate Vaccine Revenue by End Users (2020-2031)
3.2.2.1 Global Conjugate Vaccine Revenue by End Users (2020-2031)
3.2.2.2 Global Conjugate Vaccine Revenue Market Share by End Users (2020-2031)
3.2.3 Conjugate Vaccine Average Selling Price (ASP) by End Users (2020-2031)
3.3 by Type and by End Users Crossing Analysis
3.3.1 Hib Vaccine of Conjugate Vaccine Revenue Market Share by End Users
3.3.2 Meningococcal Vaccine of Conjugate Vaccine Revenue Market Share by End Users
3.3.3 Pneumococcal Vaccine of Conjugate Vaccine Revenue Market Share by End Users
3.3.4 Others of Conjugate Vaccine Revenue Market Share by End Users
4 Global Conjugate Vaccine by Manufacturers
4.1 Global Top Conjugate Vaccine Manufacturers by Sales (2020-2025)
4.1.1 Global Conjugate Vaccine Sales by Manufacturer (2020-2025)
4.1.2 Global Conjugate Vaccine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Conjugate Vaccine Manufacturers by Revenue (2020-2025)
4.2.1 Global Conjugate Vaccine Revenue by Manufacturer (2020-2025)
4.2.2 Global Conjugate Vaccine Revenue Share by Manufacturer (2020-2025)
4.3 Global Conjugate Vaccine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Conjugate Vaccine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Conjugate Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Conjugate Vaccine Manufacturing Base Distribution, Product Type
4.5.1 Conjugate Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Conjugate Vaccine Market
4.5.3 Manufacturers Conjugate Vaccine Product Type and Application
4.5.4 Hib Vaccine Market Sales of Conjugate Vaccine by Manufacturer
4.5.5 Meningococcal Vaccine Market Sales of Conjugate Vaccine by Manufacturer
4.5.6 Pneumococcal Vaccine Market Sales of Conjugate Vaccine by Manufacturer
4.5.7 Others Market Sales of Conjugate Vaccine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Pfizer
5.1.1 Pfizer Company Information
5.1.2 Pfizer Description, Business Overview
5.1.3 Pfizer Conjugate Vaccine Products Offered
5.1.4 Pfizer Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Pfizer Conjugate Vaccine Sales by Product in 2024
5.1.6 Pfizer Conjugate Vaccine Sales by End Users in 2024
5.1.7 Pfizer Conjugate Vaccine Sales by Geographic Area in 2024
5.1.8 Pfizer Recent Developments
5.2 GSK
5.2.1 GSK Company Information
5.2.2 GSK Description, Business Overview
5.2.3 GSK Conjugate Vaccine Products Offered
5.2.4 GSK Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 GSK Conjugate Vaccine Sales by Product in 2024
5.2.6 GSK Conjugate Vaccine Sales by End Users in 2024
5.2.7 GSK Conjugate Vaccine Sales by Geographic Area in 2024
5.2.8 GSK Recent Developments
5.3 Sanofi
5.3.1 Sanofi Company Information
5.3.2 Sanofi Description, Business Overview
5.3.3 Sanofi Conjugate Vaccine Products Offered
5.3.4 Sanofi Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Sanofi Conjugate Vaccine Sales by Product in 2024
5.3.6 Sanofi Conjugate Vaccine Sales by End Users in 2024
5.3.7 Sanofi Conjugate Vaccine Sales by Geographic Area in 2024
5.3.8 Sanofi Recent Developments
5.4 Merck
5.4.1 Merck Company Information
5.4.2 Merck Description, Business Overview
5.4.3 Merck Conjugate Vaccine Products Offered
5.4.4 Merck Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Merck Conjugate Vaccine Sales by Product in 2024
5.4.6 Merck Conjugate Vaccine Sales by End Users in 2024
5.4.7 Merck Conjugate Vaccine Sales by Geographic Area in 2024
5.4.8 Merck Recent Developments
5.5 Walvax Biotechnology
5.5.1 Walvax Biotechnology Company Information
5.5.2 Walvax Biotechnology Description, Business Overview
5.5.3 Walvax Biotechnology Conjugate Vaccine Products Offered
5.5.4 Walvax Biotechnology Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Walvax Biotechnology Conjugate Vaccine Sales by Product in 2024
5.5.6 Walvax Biotechnology Conjugate Vaccine Sales by End Users in 2024
5.5.7 Walvax Biotechnology Conjugate Vaccine Sales by Geographic Area in 2024
5.5.8 Walvax Biotechnology Recent Developments
5.6 Royal (Wuxi) Bio-Pharmaceutical
5.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
5.6.2 Royal (Wuxi) Bio-Pharmaceutical Description, Business Overview
5.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Products Offered
5.6.4 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales by Product in 2024
5.6.6 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales by End Users in 2024
5.6.7 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales by Geographic Area in 2024
5.6.8 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
5.7 Bharat Biotech
5.7.1 Bharat Biotech Company Information
5.7.2 Bharat Biotech Description, Business Overview
5.7.3 Bharat Biotech Conjugate Vaccine Products Offered
5.7.4 Bharat Biotech Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Bharat Biotech Conjugate Vaccine Sales by Product in 2024
5.7.6 Bharat Biotech Conjugate Vaccine Sales by End Users in 2024
5.7.7 Bharat Biotech Conjugate Vaccine Sales by Geographic Area in 2024
5.7.8 Bharat Biotech Recent Developments
5.8 Zhifei Biologic
5.8.1 Zhifei Biologic Company Information
5.8.2 Zhifei Biologic Description, Business Overview
5.8.3 Zhifei Biologic Conjugate Vaccine Products Offered
5.8.4 Zhifei Biologic Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Zhifei Biologic Conjugate Vaccine Sales by Product in 2024
5.8.6 Zhifei Biologic Conjugate Vaccine Sales by End Users in 2024
5.8.7 Zhifei Biologic Conjugate Vaccine Sales by Geographic Area in 2024
5.8.8 Zhifei Biologic Recent Developments
6 North America
6.1 North America Conjugate Vaccine Market Size YoY Growth 2020-2031
6.2 North America Conjugate Vaccine Market Facts & Figures by Country
6.2.1 North America Conjugate Vaccine Sales by Country (2020-2031)
6.2.2 North America Conjugate Vaccine Revenue by Country (2020-2031)
6.3 North America Conjugate Vaccine Sales by Type (2020-2025)
6.4 North America Conjugate Vaccine Sales by End Users (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Conjugate Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Conjugate Vaccine Market Facts & Figures by Region
7.2.1 Asia-Pacific Conjugate Vaccine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Conjugate Vaccine Revenue by Region (2020-2031)
7.3 Asia-Pacific Conjugate Vaccine Sales by Type (2020-2025)
7.4 Asia-Pacific Conjugate Vaccine Sales by End Users (2020-2025)
8 Europe
8.1 Europe Conjugate Vaccine Market Size YoY Growth 2020-2031
8.2 Europe Conjugate Vaccine Market Facts & Figures by Country
8.2.1 Europe Conjugate Vaccine Sales by Country (2020-2031)
8.2.2 Europe Conjugate Vaccine Revenue by Country (2020-2031)
8.3 Europe Conjugate Vaccine Sales by Type (2020-2025)
8.4 Europe Conjugate Vaccine Sales by End Users (2020-2025)
9 Latin America
9.1 Latin America Conjugate Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America Conjugate Vaccine Market Facts & Figures by Country
9.2.1 Latin America Conjugate Vaccine Sales by Country (2020-2031)
9.2.2 Latin America Conjugate Vaccine Revenue by Country (2020-2031)
9.3 Latin America Conjugate Vaccine Sales by Type (2020-2025)
9.4 Latin America Conjugate Vaccine Sales by End Users (2020-2025)
10 Middle East and Africa
10.1 Latin America Conjugate Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Conjugate Vaccine Market Facts & Figures by Country
10.2.1 Middle East and Africa Conjugate Vaccine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Conjugate Vaccine Revenue by Country (2020-2031)
10.3 Middle East and Africa Conjugate Vaccine Sales by Type (2020-2025)
10.4 Middle East and Africa Conjugate Vaccine Sales by End Users (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Conjugate Vaccine Supply Chain Analysis
11.2 Conjugate Vaccine Key Raw Materials and Upstream Suppliers
11.3 Conjugate Vaccine Clients Analysis
11.4 Conjugate Vaccine Sales Channel and Sales Model Analysis
11.4.1 Conjugate Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Conjugate Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Conjugate Vaccine Distributors
12 Conjugate Vaccine Market Dynamics
12.1 Conjugate Vaccine Industry Trends
12.2 Conjugate Vaccine Market Drivers
12.3 Conjugate Vaccine Market Challenges
12.4 Conjugate Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Conjugate Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Conjugate Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Hib Vaccine
1.2.3 Meningococcal Vaccine
1.2.4 Pneumococcal Vaccine
1.2.5 Others
1.3 Market by End Users
1.3.1 Global Conjugate Vaccine Market Size Growth Rate by End Users (2020 VS 2024 VS 2031)
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Conjugate Vaccine Market Size Estimates and Forecasts
2.1.1 Global Conjugate Vaccine Revenue 2020-2031
2.1.2 Global Conjugate Vaccine Sales 2020-2031
2.2 Conjugate Vaccine Market Size by Region: 2024 Versus 2031
2.3 Conjugate Vaccine Sales by Region (2020-2031)
2.3.1 Global Conjugate Vaccine Sales by Region: 2020-2025
2.3.2 Global Conjugate Vaccine Sales Forecast by Region (2026-2031)
2.3.3 Global Conjugate Vaccine Sales Market Share by Region (2020-2031)
2.4 Conjugate Vaccine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Conjugate Vaccine Revenue by Region: 2020-2025
2.4.2 Global Conjugate Vaccine Revenue Forecast by Region (2026-2031)
2.4.3 Global Conjugate Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Conjugate Vaccine Sales by Type (2020-2031)
3.1.1.1 Global Conjugate Vaccine Sales Volume by Type (2020-2031)
3.1.1.2 Global Conjugate Vaccine Sales Market Share by Type (2020-2031)
3.1.2 Global Conjugate Vaccine Revenue by Type (2020-2031)
3.1.2.1 Global Conjugate Vaccine Revenue by Type (2020-2031)
3.1.2.2 Global Conjugate Vaccine Revenue Market Share by Type (2020-2031)
3.1.3 Conjugate Vaccine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by End Users
3.2.1 Global Conjugate Vaccine Sales by End Users (2020-2031)
3.2.1.1 Global Conjugate Vaccine Sales Volume by End Users (2020-2031)
3.2.1.2 Global Conjugate Vaccine Sales Market Share by End Users (2020-2031)
3.2.2 Global Conjugate Vaccine Revenue by End Users (2020-2031)
3.2.2.1 Global Conjugate Vaccine Revenue by End Users (2020-2031)
3.2.2.2 Global Conjugate Vaccine Revenue Market Share by End Users (2020-2031)
3.2.3 Conjugate Vaccine Average Selling Price (ASP) by End Users (2020-2031)
3.3 by Type and by End Users Crossing Analysis
3.3.1 Hib Vaccine of Conjugate Vaccine Revenue Market Share by End Users
3.3.2 Meningococcal Vaccine of Conjugate Vaccine Revenue Market Share by End Users
3.3.3 Pneumococcal Vaccine of Conjugate Vaccine Revenue Market Share by End Users
3.3.4 Others of Conjugate Vaccine Revenue Market Share by End Users
4 Global Conjugate Vaccine by Manufacturers
4.1 Global Top Conjugate Vaccine Manufacturers by Sales (2020-2025)
4.1.1 Global Conjugate Vaccine Sales by Manufacturer (2020-2025)
4.1.2 Global Conjugate Vaccine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Conjugate Vaccine Manufacturers by Revenue (2020-2025)
4.2.1 Global Conjugate Vaccine Revenue by Manufacturer (2020-2025)
4.2.2 Global Conjugate Vaccine Revenue Share by Manufacturer (2020-2025)
4.3 Global Conjugate Vaccine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Conjugate Vaccine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Conjugate Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Conjugate Vaccine Manufacturing Base Distribution, Product Type
4.5.1 Conjugate Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Conjugate Vaccine Market
4.5.3 Manufacturers Conjugate Vaccine Product Type and Application
4.5.4 Hib Vaccine Market Sales of Conjugate Vaccine by Manufacturer
4.5.5 Meningococcal Vaccine Market Sales of Conjugate Vaccine by Manufacturer
4.5.6 Pneumococcal Vaccine Market Sales of Conjugate Vaccine by Manufacturer
4.5.7 Others Market Sales of Conjugate Vaccine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Pfizer
5.1.1 Pfizer Company Information
5.1.2 Pfizer Description, Business Overview
5.1.3 Pfizer Conjugate Vaccine Products Offered
5.1.4 Pfizer Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Pfizer Conjugate Vaccine Sales by Product in 2024
5.1.6 Pfizer Conjugate Vaccine Sales by End Users in 2024
5.1.7 Pfizer Conjugate Vaccine Sales by Geographic Area in 2024
5.1.8 Pfizer Recent Developments
5.2 GSK
5.2.1 GSK Company Information
5.2.2 GSK Description, Business Overview
5.2.3 GSK Conjugate Vaccine Products Offered
5.2.4 GSK Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 GSK Conjugate Vaccine Sales by Product in 2024
5.2.6 GSK Conjugate Vaccine Sales by End Users in 2024
5.2.7 GSK Conjugate Vaccine Sales by Geographic Area in 2024
5.2.8 GSK Recent Developments
5.3 Sanofi
5.3.1 Sanofi Company Information
5.3.2 Sanofi Description, Business Overview
5.3.3 Sanofi Conjugate Vaccine Products Offered
5.3.4 Sanofi Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Sanofi Conjugate Vaccine Sales by Product in 2024
5.3.6 Sanofi Conjugate Vaccine Sales by End Users in 2024
5.3.7 Sanofi Conjugate Vaccine Sales by Geographic Area in 2024
5.3.8 Sanofi Recent Developments
5.4 Merck
5.4.1 Merck Company Information
5.4.2 Merck Description, Business Overview
5.4.3 Merck Conjugate Vaccine Products Offered
5.4.4 Merck Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Merck Conjugate Vaccine Sales by Product in 2024
5.4.6 Merck Conjugate Vaccine Sales by End Users in 2024
5.4.7 Merck Conjugate Vaccine Sales by Geographic Area in 2024
5.4.8 Merck Recent Developments
5.5 Walvax Biotechnology
5.5.1 Walvax Biotechnology Company Information
5.5.2 Walvax Biotechnology Description, Business Overview
5.5.3 Walvax Biotechnology Conjugate Vaccine Products Offered
5.5.4 Walvax Biotechnology Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Walvax Biotechnology Conjugate Vaccine Sales by Product in 2024
5.5.6 Walvax Biotechnology Conjugate Vaccine Sales by End Users in 2024
5.5.7 Walvax Biotechnology Conjugate Vaccine Sales by Geographic Area in 2024
5.5.8 Walvax Biotechnology Recent Developments
5.6 Royal (Wuxi) Bio-Pharmaceutical
5.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
5.6.2 Royal (Wuxi) Bio-Pharmaceutical Description, Business Overview
5.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Products Offered
5.6.4 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales by Product in 2024
5.6.6 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales by End Users in 2024
5.6.7 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales by Geographic Area in 2024
5.6.8 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
5.7 Bharat Biotech
5.7.1 Bharat Biotech Company Information
5.7.2 Bharat Biotech Description, Business Overview
5.7.3 Bharat Biotech Conjugate Vaccine Products Offered
5.7.4 Bharat Biotech Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Bharat Biotech Conjugate Vaccine Sales by Product in 2024
5.7.6 Bharat Biotech Conjugate Vaccine Sales by End Users in 2024
5.7.7 Bharat Biotech Conjugate Vaccine Sales by Geographic Area in 2024
5.7.8 Bharat Biotech Recent Developments
5.8 Zhifei Biologic
5.8.1 Zhifei Biologic Company Information
5.8.2 Zhifei Biologic Description, Business Overview
5.8.3 Zhifei Biologic Conjugate Vaccine Products Offered
5.8.4 Zhifei Biologic Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Zhifei Biologic Conjugate Vaccine Sales by Product in 2024
5.8.6 Zhifei Biologic Conjugate Vaccine Sales by End Users in 2024
5.8.7 Zhifei Biologic Conjugate Vaccine Sales by Geographic Area in 2024
5.8.8 Zhifei Biologic Recent Developments
6 North America
6.1 North America Conjugate Vaccine Market Size YoY Growth 2020-2031
6.2 North America Conjugate Vaccine Market Facts & Figures by Country
6.2.1 North America Conjugate Vaccine Sales by Country (2020-2031)
6.2.2 North America Conjugate Vaccine Revenue by Country (2020-2031)
6.3 North America Conjugate Vaccine Sales by Type (2020-2025)
6.4 North America Conjugate Vaccine Sales by End Users (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Conjugate Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Conjugate Vaccine Market Facts & Figures by Region
7.2.1 Asia-Pacific Conjugate Vaccine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Conjugate Vaccine Revenue by Region (2020-2031)
7.3 Asia-Pacific Conjugate Vaccine Sales by Type (2020-2025)
7.4 Asia-Pacific Conjugate Vaccine Sales by End Users (2020-2025)
8 Europe
8.1 Europe Conjugate Vaccine Market Size YoY Growth 2020-2031
8.2 Europe Conjugate Vaccine Market Facts & Figures by Country
8.2.1 Europe Conjugate Vaccine Sales by Country (2020-2031)
8.2.2 Europe Conjugate Vaccine Revenue by Country (2020-2031)
8.3 Europe Conjugate Vaccine Sales by Type (2020-2025)
8.4 Europe Conjugate Vaccine Sales by End Users (2020-2025)
9 Latin America
9.1 Latin America Conjugate Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America Conjugate Vaccine Market Facts & Figures by Country
9.2.1 Latin America Conjugate Vaccine Sales by Country (2020-2031)
9.2.2 Latin America Conjugate Vaccine Revenue by Country (2020-2031)
9.3 Latin America Conjugate Vaccine Sales by Type (2020-2025)
9.4 Latin America Conjugate Vaccine Sales by End Users (2020-2025)
10 Middle East and Africa
10.1 Latin America Conjugate Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Conjugate Vaccine Market Facts & Figures by Country
10.2.1 Middle East and Africa Conjugate Vaccine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Conjugate Vaccine Revenue by Country (2020-2031)
10.3 Middle East and Africa Conjugate Vaccine Sales by Type (2020-2025)
10.4 Middle East and Africa Conjugate Vaccine Sales by End Users (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Conjugate Vaccine Supply Chain Analysis
11.2 Conjugate Vaccine Key Raw Materials and Upstream Suppliers
11.3 Conjugate Vaccine Clients Analysis
11.4 Conjugate Vaccine Sales Channel and Sales Model Analysis
11.4.1 Conjugate Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Conjugate Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Conjugate Vaccine Distributors
12 Conjugate Vaccine Market Dynamics
12.1 Conjugate Vaccine Industry Trends
12.2 Conjugate Vaccine Market Drivers
12.3 Conjugate Vaccine Market Challenges
12.4 Conjugate Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Conjugate Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Conjugate Vaccine Market Size Growth by End Users (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Conjugate Vaccine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Conjugate Vaccine Sales by Region (2020-2025) & (Million Unit)
Table 5. Global Conjugate Vaccine Sales Forecast by Region (2026-2031) & (Million Unit)
Table 6. Global Conjugate Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Conjugate Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Conjugate Vaccine Sales Volume by Type (2020-2025) & (Million Unit)
Table 9. Global Conjugate Vaccine Sales Volume by Type (2026-2031) & (Million Unit)
Table 10. Global Conjugate Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Conjugate Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Conjugate Vaccine Sales Volume by End Users (2020-2025) & (Million Unit)
Table 13. Global Conjugate Vaccine Sales Volume by End Users (2026-2031) & (Million Unit)
Table 14. Global Conjugate Vaccine Revenue by End Users (2020-2025) & (US$ Million)
Table 15. Global Conjugate Vaccine Revenue by End Users (2026-2031) & (US$ Million)
Table 16. Global Conjugate Vaccine Sales by Manufacturer (2020-2025) & (Million Unit)
Table 17. Global Conjugate Vaccine Sales Share by Manufacturer (2020-2025)
Table 18. Conjugate Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Conjugate Vaccine Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Conjugate Vaccine Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Conjugate Vaccine Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Conjugate Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Conjugate Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjugate Vaccine as of 2024)
Table 24. Conjugate Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Conjugate Vaccine Market
Table 26. Manufacturers Conjugate Vaccine Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Pfizer Company Information
Table 29. Pfizer Description and Business Overview
Table 30. Pfizer Conjugate Vaccine Product
Table 31. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Pfizer Sales Proportion of Conjugate Vaccine by Product in 2024
Table 33. Pfizer Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 34. Pfizer Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 35. Pfizer Recent Developments
Table 36. GSK Company Information
Table 37. GSK Description and Business Overview
Table 38. GSK Conjugate Vaccine Product
Table 39. GSK Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. GSK Sales Proportion of Conjugate Vaccine by Product in 2024
Table 41. GSK Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 42. GSK Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 43. GSK Recent Developments
Table 44. Sanofi Company Information
Table 45. Sanofi Description and Business Overview
Table 46. Sanofi Conjugate Vaccine Product
Table 47. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Sanofi Sales Proportion of Conjugate Vaccine by Product in 2024
Table 49. Sanofi Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 50. Sanofi Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 51. Sanofi Recent Developments
Table 52. Merck Company Information
Table 53. Merck Description and Business Overview
Table 54. Merck Conjugate Vaccine Product
Table 55. Merck Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Merck Sales Proportion of Conjugate Vaccine by Product in 2024
Table 57. Merck Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 58. Merck Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 59. Merck Recent Developments
Table 60. Walvax Biotechnology Company Information
Table 61. Walvax Biotechnology Description and Business Overview
Table 62. Walvax Biotechnology Conjugate Vaccine Product
Table 63. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Walvax Biotechnology Sales Proportion of Conjugate Vaccine by Product in 2024
Table 65. Walvax Biotechnology Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 66. Walvax Biotechnology Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 67. Walvax Biotechnology Recent Developments
Table 68. Royal (Wuxi) Bio-Pharmaceutical Company Information
Table 69. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
Table 70. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product
Table 71. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Royal (Wuxi) Bio-Pharmaceutical Sales Proportion of Conjugate Vaccine by Product in 2024
Table 73. Royal (Wuxi) Bio-Pharmaceutical Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 74. Royal (Wuxi) Bio-Pharmaceutical Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 75. Royal (Wuxi) Bio-Pharmaceutical Recent Developments
Table 76. Bharat Biotech Company Information
Table 77. Bharat Biotech Description and Business Overview
Table 78. Bharat Biotech Conjugate Vaccine Product
Table 79. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Bharat Biotech Sales Proportion of Conjugate Vaccine by Product in 2024
Table 81. Bharat Biotech Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 82. Bharat Biotech Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 83. Bharat Biotech Recent Developments
Table 84. Zhifei Biologic Company Information
Table 85. Zhifei Biologic Description and Business Overview
Table 86. Zhifei Biologic Conjugate Vaccine Product
Table 87. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Zhifei Biologic Sales Proportion of Conjugate Vaccine by Product in 2024
Table 89. Zhifei Biologic Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 90. Zhifei Biologic Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 91. Zhifei Biologic Recent Developments
Table 92. North America Conjugate Vaccine Sales by Country (2020-2025) & (Million Unit)
Table 93. North America Conjugate Vaccine Sales by Country (2026-2031) & (Million Unit)
Table 94. North America Conjugate Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 95. North America Conjugate Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 96. North America Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 97. North America Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 98. Asia-Pacific Conjugate Vaccine Sales by Region (2020-2025) & (Million Unit)
Table 99. Asia-Pacific Conjugate Vaccine Sales by Region (2026-2031) & (Million Unit)
Table 100. Asia-Pacific Conjugate Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 101. Asia-Pacific Conjugate Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 102. Asia-Pacific Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 103. Asia-Pacific Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 104. Europe Conjugate Vaccine Sales by Country (2020-2025) & (Million Unit)
Table 105. Europe Conjugate Vaccine Sales by Country (2026-2031) & (Million Unit)
Table 106. Europe Conjugate Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 107. Europe Conjugate Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 108. Europe Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 109. Europe Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 110. Latin America Conjugate Vaccine Sales by Country (2020-2025) & (Million Unit)
Table 111. Latin America Conjugate Vaccine Sales by Country (2026-2031) & (Million Unit)
Table 112. Latin America Conjugate Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 113. Latin America Conjugate Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 114. Latin America Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 115. Latin America Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 116. Middle East and Africa Conjugate Vaccine Sales by Country (2020-2025) & (Million Unit)
Table 117. Middle East and Africa Conjugate Vaccine Sales by Country (2026-2031) & (Million Unit)
Table 118. Middle East and Africa Conjugate Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 119. Middle East and Africa Conjugate Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 120. Middle East and Africa Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 121. Middle East and Africa Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 122. Conjugate Vaccine Key Raw Materials, Industry Status and Trend
Table 123. Conjugate Vaccine Key Raw Materials and Upstream Suppliers
Table 124. Conjugate Vaccine Clients Status and Trend
Table 125. Conjugate Vaccine Typical Clients
Table 126. Conjugate Vaccine Distributors
Table 127. Conjugate Vaccine Market Trends
Table 128. Conjugate Vaccine Market Drivers
Table 129. Conjugate Vaccine Market Challenges
Table 130. Conjugate Vaccine Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Conjugate Vaccine Product Picture
Figure 2. Global Conjugate Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Conjugate Vaccine Sales Market Share by Type in 2024 & 2031
Figure 4. Hib Vaccine Product Picture
Figure 5. Meningococcal Vaccine Product Picture
Figure 6. Pneumococcal Vaccine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Conjugate Vaccine Market Size by End Users (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Conjugate Vaccine Sales Market Share by End Users in 2024 & 2031
Figure 10. Children
Figure 11. Adult
Figure 12. Conjugate Vaccine Report Years Considered
Figure 13. Global Conjugate Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Conjugate Vaccine Market Size 2020-2031 (US$ Million)
Figure 15. Global Conjugate Vaccine Sales 2020-2031 (Million Unit)
Figure 16. Global Conjugate Vaccine Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Conjugate Vaccine Revenue Market Share by Region (2020-2031)
Figure 18. Global Conjugate Vaccine Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Conjugate Vaccine Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Conjugate Vaccine Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 21. Global Conjugate Vaccine Sales Market Share Forecast by End Users (2020-2031)
Figure 22. Global Conjugate Vaccine Revenue Market Share Forecast by End Users (2020-2031)
Figure 23. Conjugate Vaccine Average Selling Price (ASP) by End Users (2020-2025) & (USD/Unit)
Figure 24. Hib Vaccine of Conjugate Vaccine Revenue Market Share by End Users, 2024 VS 2031
Figure 25. Meningococcal Vaccine of Conjugate Vaccine Revenue Market Share by End Users, 2024 VS 2031
Figure 26. Pneumococcal Vaccine of Conjugate Vaccine Revenue Market Share by End Users, 2024 VS 2031
Figure 27. Others of Conjugate Vaccine Revenue Market Share by End Users, 2024 VS 2031
Figure 28. Global Conjugate Vaccine Sales Share by Manufacturer in 2024
Figure 29. Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 30. Hib Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 31. Meningococcal Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 32. Pneumococcal Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 33. Others Market Sales Proportion by Manufacturer in 2024
Figure 34. North America Conjugate Vaccine Revenue 2020-2031 (US$ Million)
Figure 35. North America Conjugate Vaccine Sales Market Share by Type (2020-2025)
Figure 36. North America Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 37. Asia-Pacific Conjugate Vaccine Revenue 2020-2031 (US$ Million)
Figure 38. Asia-Pacific Conjugate Vaccine Sales Market Share by Region (2020-2031)
Figure 39. Asia-Pacific Conjugate Vaccine Revenue Market Share by Region (2020-2031)
Figure 40. Asia-Pacific Conjugate Vaccine Sales Market Share by Type (2020-2025)
Figure 41. Asia-Pacific Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 42. Europe Conjugate Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Europe Conjugate Vaccine Sales Market Share by Country (2020-2031)
Figure 44. Europe Conjugate Vaccine Revenue Market Share by Country (2020-2031)
Figure 45. Europe Conjugate Vaccine Sales Market Share by Type (2020-2025)
Figure 46. Europe Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 47. Latin America Conjugate Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Latin America Conjugate Vaccine Sales Market Share by Country (2020-2031)
Figure 49. Latin America Conjugate Vaccine Revenue Market Share by Country (2020-2025)
Figure 50. Latin America Conjugate Vaccine Sales Market Share by Type (2020-2025)
Figure 51. Latin America Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 52. Middle East and Africa Conjugate Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 53. Middle East and Africa Conjugate Vaccine Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Conjugate Vaccine Revenue Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Conjugate Vaccine Sales Market Share by Type (2020-2025)
Figure 56. Middle East and Africa Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 57. Conjugate Vaccine Supply Chain (Upstream and Downstream Market)
Figure 58. Global Production Market Share of Conjugate Vaccine Raw Materials by Region in 2024
Figure 59. Conjugate Vaccine Distribution Channels
Figure 60. Global Conjugate Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 61. Global Conjugate Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Conjugate Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Conjugate Vaccine Market Size Growth by End Users (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Conjugate Vaccine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Conjugate Vaccine Sales by Region (2020-2025) & (Million Unit)
Table 5. Global Conjugate Vaccine Sales Forecast by Region (2026-2031) & (Million Unit)
Table 6. Global Conjugate Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Conjugate Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Conjugate Vaccine Sales Volume by Type (2020-2025) & (Million Unit)
Table 9. Global Conjugate Vaccine Sales Volume by Type (2026-2031) & (Million Unit)
Table 10. Global Conjugate Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Conjugate Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Conjugate Vaccine Sales Volume by End Users (2020-2025) & (Million Unit)
Table 13. Global Conjugate Vaccine Sales Volume by End Users (2026-2031) & (Million Unit)
Table 14. Global Conjugate Vaccine Revenue by End Users (2020-2025) & (US$ Million)
Table 15. Global Conjugate Vaccine Revenue by End Users (2026-2031) & (US$ Million)
Table 16. Global Conjugate Vaccine Sales by Manufacturer (2020-2025) & (Million Unit)
Table 17. Global Conjugate Vaccine Sales Share by Manufacturer (2020-2025)
Table 18. Conjugate Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Conjugate Vaccine Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Conjugate Vaccine Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Conjugate Vaccine Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Conjugate Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Conjugate Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjugate Vaccine as of 2024)
Table 24. Conjugate Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Conjugate Vaccine Market
Table 26. Manufacturers Conjugate Vaccine Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Pfizer Company Information
Table 29. Pfizer Description and Business Overview
Table 30. Pfizer Conjugate Vaccine Product
Table 31. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Pfizer Sales Proportion of Conjugate Vaccine by Product in 2024
Table 33. Pfizer Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 34. Pfizer Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 35. Pfizer Recent Developments
Table 36. GSK Company Information
Table 37. GSK Description and Business Overview
Table 38. GSK Conjugate Vaccine Product
Table 39. GSK Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. GSK Sales Proportion of Conjugate Vaccine by Product in 2024
Table 41. GSK Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 42. GSK Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 43. GSK Recent Developments
Table 44. Sanofi Company Information
Table 45. Sanofi Description and Business Overview
Table 46. Sanofi Conjugate Vaccine Product
Table 47. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Sanofi Sales Proportion of Conjugate Vaccine by Product in 2024
Table 49. Sanofi Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 50. Sanofi Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 51. Sanofi Recent Developments
Table 52. Merck Company Information
Table 53. Merck Description and Business Overview
Table 54. Merck Conjugate Vaccine Product
Table 55. Merck Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Merck Sales Proportion of Conjugate Vaccine by Product in 2024
Table 57. Merck Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 58. Merck Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 59. Merck Recent Developments
Table 60. Walvax Biotechnology Company Information
Table 61. Walvax Biotechnology Description and Business Overview
Table 62. Walvax Biotechnology Conjugate Vaccine Product
Table 63. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Walvax Biotechnology Sales Proportion of Conjugate Vaccine by Product in 2024
Table 65. Walvax Biotechnology Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 66. Walvax Biotechnology Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 67. Walvax Biotechnology Recent Developments
Table 68. Royal (Wuxi) Bio-Pharmaceutical Company Information
Table 69. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
Table 70. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product
Table 71. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Royal (Wuxi) Bio-Pharmaceutical Sales Proportion of Conjugate Vaccine by Product in 2024
Table 73. Royal (Wuxi) Bio-Pharmaceutical Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 74. Royal (Wuxi) Bio-Pharmaceutical Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 75. Royal (Wuxi) Bio-Pharmaceutical Recent Developments
Table 76. Bharat Biotech Company Information
Table 77. Bharat Biotech Description and Business Overview
Table 78. Bharat Biotech Conjugate Vaccine Product
Table 79. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Bharat Biotech Sales Proportion of Conjugate Vaccine by Product in 2024
Table 81. Bharat Biotech Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 82. Bharat Biotech Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 83. Bharat Biotech Recent Developments
Table 84. Zhifei Biologic Company Information
Table 85. Zhifei Biologic Description and Business Overview
Table 86. Zhifei Biologic Conjugate Vaccine Product
Table 87. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Zhifei Biologic Sales Proportion of Conjugate Vaccine by Product in 2024
Table 89. Zhifei Biologic Sales Proportion of Conjugate Vaccine by End Users in 2024
Table 90. Zhifei Biologic Sales Proportion of Conjugate Vaccine by Geographic Area in 2024
Table 91. Zhifei Biologic Recent Developments
Table 92. North America Conjugate Vaccine Sales by Country (2020-2025) & (Million Unit)
Table 93. North America Conjugate Vaccine Sales by Country (2026-2031) & (Million Unit)
Table 94. North America Conjugate Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 95. North America Conjugate Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 96. North America Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 97. North America Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 98. Asia-Pacific Conjugate Vaccine Sales by Region (2020-2025) & (Million Unit)
Table 99. Asia-Pacific Conjugate Vaccine Sales by Region (2026-2031) & (Million Unit)
Table 100. Asia-Pacific Conjugate Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 101. Asia-Pacific Conjugate Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 102. Asia-Pacific Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 103. Asia-Pacific Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 104. Europe Conjugate Vaccine Sales by Country (2020-2025) & (Million Unit)
Table 105. Europe Conjugate Vaccine Sales by Country (2026-2031) & (Million Unit)
Table 106. Europe Conjugate Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 107. Europe Conjugate Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 108. Europe Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 109. Europe Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 110. Latin America Conjugate Vaccine Sales by Country (2020-2025) & (Million Unit)
Table 111. Latin America Conjugate Vaccine Sales by Country (2026-2031) & (Million Unit)
Table 112. Latin America Conjugate Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 113. Latin America Conjugate Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 114. Latin America Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 115. Latin America Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 116. Middle East and Africa Conjugate Vaccine Sales by Country (2020-2025) & (Million Unit)
Table 117. Middle East and Africa Conjugate Vaccine Sales by Country (2026-2031) & (Million Unit)
Table 118. Middle East and Africa Conjugate Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 119. Middle East and Africa Conjugate Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 120. Middle East and Africa Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 121. Middle East and Africa Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 122. Conjugate Vaccine Key Raw Materials, Industry Status and Trend
Table 123. Conjugate Vaccine Key Raw Materials and Upstream Suppliers
Table 124. Conjugate Vaccine Clients Status and Trend
Table 125. Conjugate Vaccine Typical Clients
Table 126. Conjugate Vaccine Distributors
Table 127. Conjugate Vaccine Market Trends
Table 128. Conjugate Vaccine Market Drivers
Table 129. Conjugate Vaccine Market Challenges
Table 130. Conjugate Vaccine Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Conjugate Vaccine Product Picture
Figure 2. Global Conjugate Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Conjugate Vaccine Sales Market Share by Type in 2024 & 2031
Figure 4. Hib Vaccine Product Picture
Figure 5. Meningococcal Vaccine Product Picture
Figure 6. Pneumococcal Vaccine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Conjugate Vaccine Market Size by End Users (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Conjugate Vaccine Sales Market Share by End Users in 2024 & 2031
Figure 10. Children
Figure 11. Adult
Figure 12. Conjugate Vaccine Report Years Considered
Figure 13. Global Conjugate Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Conjugate Vaccine Market Size 2020-2031 (US$ Million)
Figure 15. Global Conjugate Vaccine Sales 2020-2031 (Million Unit)
Figure 16. Global Conjugate Vaccine Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Conjugate Vaccine Revenue Market Share by Region (2020-2031)
Figure 18. Global Conjugate Vaccine Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Conjugate Vaccine Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Conjugate Vaccine Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 21. Global Conjugate Vaccine Sales Market Share Forecast by End Users (2020-2031)
Figure 22. Global Conjugate Vaccine Revenue Market Share Forecast by End Users (2020-2031)
Figure 23. Conjugate Vaccine Average Selling Price (ASP) by End Users (2020-2025) & (USD/Unit)
Figure 24. Hib Vaccine of Conjugate Vaccine Revenue Market Share by End Users, 2024 VS 2031
Figure 25. Meningococcal Vaccine of Conjugate Vaccine Revenue Market Share by End Users, 2024 VS 2031
Figure 26. Pneumococcal Vaccine of Conjugate Vaccine Revenue Market Share by End Users, 2024 VS 2031
Figure 27. Others of Conjugate Vaccine Revenue Market Share by End Users, 2024 VS 2031
Figure 28. Global Conjugate Vaccine Sales Share by Manufacturer in 2024
Figure 29. Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 30. Hib Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 31. Meningococcal Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 32. Pneumococcal Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 33. Others Market Sales Proportion by Manufacturer in 2024
Figure 34. North America Conjugate Vaccine Revenue 2020-2031 (US$ Million)
Figure 35. North America Conjugate Vaccine Sales Market Share by Type (2020-2025)
Figure 36. North America Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 37. Asia-Pacific Conjugate Vaccine Revenue 2020-2031 (US$ Million)
Figure 38. Asia-Pacific Conjugate Vaccine Sales Market Share by Region (2020-2031)
Figure 39. Asia-Pacific Conjugate Vaccine Revenue Market Share by Region (2020-2031)
Figure 40. Asia-Pacific Conjugate Vaccine Sales Market Share by Type (2020-2025)
Figure 41. Asia-Pacific Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 42. Europe Conjugate Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Europe Conjugate Vaccine Sales Market Share by Country (2020-2031)
Figure 44. Europe Conjugate Vaccine Revenue Market Share by Country (2020-2031)
Figure 45. Europe Conjugate Vaccine Sales Market Share by Type (2020-2025)
Figure 46. Europe Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 47. Latin America Conjugate Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Latin America Conjugate Vaccine Sales Market Share by Country (2020-2031)
Figure 49. Latin America Conjugate Vaccine Revenue Market Share by Country (2020-2025)
Figure 50. Latin America Conjugate Vaccine Sales Market Share by Type (2020-2025)
Figure 51. Latin America Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 52. Middle East and Africa Conjugate Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 53. Middle East and Africa Conjugate Vaccine Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Conjugate Vaccine Revenue Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Conjugate Vaccine Sales Market Share by Type (2020-2025)
Figure 56. Middle East and Africa Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 57. Conjugate Vaccine Supply Chain (Upstream and Downstream Market)
Figure 58. Global Production Market Share of Conjugate Vaccine Raw Materials by Region in 2024
Figure 59. Conjugate Vaccine Distribution Channels
Figure 60. Global Conjugate Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 61. Global Conjugate Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232